Lectenz Bio attended and sponsored the Society for Glycobiology 2021 Annual Meeting in San Diego. Dr. Shaza Abnouf and Christian...
Lectenz Bio News
Lectenz Bio Signs Distribution Agreement with Hölzel Diagnostika
Lectenz Bio has recently signed a distribution agreement with Hölzel Diagnostika, a life sciences distributor. This agreement will allow...
Lectenz Bio Signs Distribution Agreement with 2B Scientific
Lectenz Bio has recently signed a distribution agreement with 2B Scientific, a life sciences distributor. This agreement will allow 2B...
Lectenz Bio Signs Distribution Agreement with Funakoshi
Lectenz Bio has recently signed a distribution agreement with Funakoshi Co., Ltd., a Japanese life science distributor. This agreement...
COVID-19 Update from Lectenz Bio
We’d like to take a brief moment to update you on our company plans as the COVID-19 situation progresses. At Lectenz Bio, our employees’...
Lectenz Bio awarded NIH NIGMS SBIR Phase I
The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop heparan...
Lectenz Bio receives NIH NIGMS SBIR Phase I
The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop...
Lectenz Bio at ACS Fall 2019 National Meeting
Lectenz Bio attended the ACS Fall 2019 National Meeting, where Dr. Matthew Saunders presented Glycosense™: Simple alternative to...
ASBMB Featured Story Highlights Lectenz Bio Founders
Lectenz Bio founders, Lori Yang and Rob Woods are highlighted in an ASBMB featured story, Setting Sail in a Startup: How academic...